The Quantikine Human Fetuin A Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human Fetuin A in cell culture supernates, serum, and plasma. It contains NS0-expressed recombinant human Fetuin A and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human Fetuin A showed linear curves that were parallel to the standard curves obtained... using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring human Fetuin A.
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human Fetuin A Quantikine ELISA Kit
A2HS
AHS
AHSG
alpha-2-HS-glycoprotein
alpha-2-Z-globulin
Ba-alpha-2-glycoprotein
FETUAba-alpha-2-glycoprotein
Fetuin A
fetuin-A
HSGA
Background
Fetuins are members of the cystatin family of proteases. Secreted by the liver, fetuins can be found at high levels in serum. Fetuin A promotes phagocytosis of apoptotic cells and plays a role in bone development, calcium homeostasis and insulin sensitivity. Fetuin B functions as an inhibitor of basic calcium phosphate precipitation.
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.
Publications for Fetuin A/AHSG (DFTA00)(11)
We have publications tested in 1 confirmed species: Human.
Discover related pathways, diseases and genes to Fetuin A/AHSG (DFTA00). Need help?
Read the Bioinformatics Tool Guide for instructions on using this tool.
Diseases for Fetuin A/AHSG (DFTA00)
Discover more about diseases related to Fetuin A/AHSG (DFTA00).
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.